Role of syndecan-1 proteoglycan in the invasiveness of HT-1080 fibrosarcoma;A syndecan-1 proteoglikán hatása a HT-1080 fibroszarkóma invazivitására

Magyar Onkologia

Volumn 50, Issue 2, 2006, Pages 115-120

  Péterfia, Bálint ^a   Hollósi, Péter ^a   Szilák, László ^b   Timár, Ferenc ^a   Paku, Sándor ^a   Jeney, András ^a   Kovalszky, Ilona ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b Szilak Labor Kft   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

MEMBRANE PROTEIN; PROTEOGLYCAN; SDC1 PROTEIN, MOUSE; SYNDECAN; SYNDECAN 1;

ANIMAL; ARTICLE; CANCER INVASION; FIBROSARCOMA; GENETIC TRANSFECTION; IMMUNOHISTOCHEMISTRY; LUNG TUMOR; METABOLISM; METASTASIS; MOUSE; PATHOLOGY; PHENOTYPE; SARCOMA; TUMOR CELL LINE;

ANIMALS; CELL LINE, TUMOR; FIBROSARCOMA; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MEMBRANE GLYCOPROTEINS; MICE; NEOPLASM INVASIVENESS; PHENOTYPE; PROTEOGLYCANS; SARCOMA, EXPERIMENTAL; SYNDECAN-1; SYNDECANS; TRANSFECTION;

EID: 33750130847     PISSN: 00250244     EISSN: 20600399     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Alexander CM, Reichsman F, Hinkes MT, et al. Syndecan- 1 is required for Wnt-1-induced mammary tumorigenesis in mice. Nat Genet 25:329-332, 2000
2. Bernfield M, Kokenyesi R, Kato M, et al. Biology of the syndecans: A family of transmembrane heparan sulfate proteoglycans. Annu Rev Cell Biol 8:365-393, 1992
3. Boudreau N, Bissel M. Extracellular matrix signaling: Integration of form and function in normal and malignant cells. Curr Opin Cell Biol 10:640-646, 1998
4. Brockstedt U, Dobra K, Nurminen M, Hjerpe A. Immunoreactivity to cell surface syndecans in cytoplasm and nucleus: Tubulin-dependent rearrangements. Exp Cell Res 274:235-245, 2002
5. Carey DJ. Syndecans: Multifunctional cell-surface coreceptors. Biochem J 327:1-16, 1997
6. Conejo JR, Kleef J, Koliopanos A, et al. Syndecan-1 expression is up-regulated in pancreatic but not in other gastrointestinal cancers. Int J Cancer 88:12-20, 2000
7. Dudas J, Ramadori G, Knittel T, et al. Effect of heparin and liver heparan sulphate on interaction of HepG2- derived transcription factors and their cis-acting elements: Altered potential of hepatocellular carcinoma heparan sulphate. Biochem J 350:245-251, 2000
8. Fujiya M, Watari J, Ashida T, et al. Reduced expression of syndecan-1 affects metastatic potential and clinical outcome in patients with colorectal cancer. Jpn J Cancer Res 92:1074-1081, 2001
9. Gallagher JT. Heparan sulfate: Growth control with a restricted sequence menu. J Clin Invest 108:357-361, 2001
10. Inki P, Jalkanen M. The role of syndecan-1 in malignancies. Ann Med 28:63-67, 1996
11. Inki P, Stenback F, Talve L, Jalkanen M. Immunohistochemical localization of syndecan in mouse skin tumors induced by UV irradiation. Loss of expression associated with malignant transformation. Am J Pathol 139:1333-1340, 1991
12. Iozzo RV, Coheen I. Altered proteoglycan expression and the tumor stroma. Experientia 49:447-455, 1993
13. Kovalszky I, Dudás J, Gallai M, et al. Proteoglikánok a májban. Magyar Onkológia 48:207-213, 2004
14. Kovalszky I, Pogány G, Molnár G, et al. Altered glycosaminoglycan composition in reactive and neoplastic human liver. Biochem Biophys Res Commun 167:883-890, 1990
15. Máthé M, Suba Z, Németh Z, et al. Stromal syndecan-1 expression is an adverse prognostic factor in oral carcinomas. Oral Oncol 42:493-500, 2006
16. Matsumoto A, Ono M, Fujimoto Y, et al. Reduced expression of syndecan-1 in human hepatocellular carcinoma with high metastatic potential. Int J Cancer 74:482-491, 1997
17. Proia DA, Kuperwasser C. Stroma: Tumor agonist or antagonist. Cell Cycle 4:1022-1025, 2005
18. Rapraeger AC. Syndecan-regulated receptor signaling. J Cell Biol 149:995-998, 2000
19. Sanderson RD, Borset M. Syndecan-1 in B lymphoid malignancies. Ann Hematol 81:125-135, 2002
20. Sanderson RD, Yang Y, Kelly T, et al. Enzymatic remodelling of heparan sulfate proteoglycans within the tumor microenvironment: Growth regulation and prospect of new cancer therapies. J Cell Biochem 96:897-905, 2005
21. Sanderson RD. Heparan sulfate proteoglycans in invasion and metastasis. Semin Cell Dev Biol 1:89-98, 2001
22. Tlsty TD, Hein PW. Know thy neighbor: Stromal cells can contribute oncogenic signals. Curr Opin Genet Dev 11:54-59, 2001
23. Wiksten JP, Lundin J, Nordling S, et al. Epithelial and stromal syndecan-1 expression as predictor of outcome in patients with gastric cancer. Int J Cancer 95:1-6, 2001
24. Yi JY, Han I, Oh ES. Transmembrane domain-dependent oligomerization of syndecans. Scientific World Journal 6:457-459, 2006